The instinctive protective stress responses of tumor cells hamper low-temperature
photothermal therapy (LTPTT), resulting in tumor recurrence and metastasis. The rapid …

The heterogeneously-distributed hyperthermia in nanomaterial-mediated photothermal
therapy commonly results in incomplete tumor eradication and serious damage of health …

Carrier-free nanodrugs composed of photosensitizers and chemotherapeutic drugs show
great potential in synergistic photothermal–chemotherapy. However, the targeting specificity …

Downregulation of adenosine triphosphate (ATP)-dependent heat shock proteins (HSPs)
can significantly reduce the tumorigenicity of cancer cells and overcome heat endurance to …

Photothermal therapy (PTT) is a promising therapeutic modality, but still faces some
potential limitations, such as unfavorable thermal damage to normal tissues, limited light …

Insufficient and heterogeneously distributed heat commonly leads to the incomplete
elimination and recurrence of tumors. Inspired by the fact that autophagy is essential for cell …

Mild photothermal therapy (PTT) shows great potential to treat cancers while avoiding
unwanted damage to surrounding normal cells. However, the efficacy of mild PTT is …

Photothermal therapy (PTT) usually requires hyperthermia> 50° C for effective tumor
ablation, which inevitably induces heating damage to the surrounding normal …

Nanoparticles camouflaged by red blood cell (RBC) membranes have attracted
considerable attention owing to reservation of structure of membrane and surface proteins …

Supramolecular nanoparticles for photothermal therapy (PTT) have shown promising
therapeutic efficacy in the primary tumor and great potential for turning the whole-body …